Literature DB >> 17175203

Sodium channel blockade may contribute to the analgesic efficacy of antidepressants.

Ivy E Dick1, Richard M Brochu, Yamini Purohit, Gregory J Kaczorowski, William J Martin, Birgit T Priest.   

Abstract

UNLABELLED: Sodium channel blockers such as lidocaine, lamotrigine, and carbamazepine can be effective in the treatment of neuropathic pain. Though not approved for neuropathic pain indications, tricyclic antidepressants are often considered first-line treatment for conditions such as post-herpetic neuralgia and diabetic neuropathy. Several tricyclic antidepressants have been shown to block peripheral nerve sodium channels, which may contribute to their antihyperalgesic efficacy. In this study, we compared the sodium channel-blocking potency of a number of antidepressants, including tricyclic antidepressants and selective serotonin reuptake inhibitors. All compounds tested inhibited Na(V)1.7 in a state- and use-dependent manner, with affinities for the inactivated state ranging from 0.24 micromol/L for amitriptyline to 11.6 micromol/L for zimelidine. The tricyclic antidepressants were more potent blockers of Na(V)1.7. Moreover, IC(50)s for block of the inactivated state for amitriptyline, nortriptyline, imipramine, desipramine, and maprotiline were in the range of therapeutic plasma concentrations for both the treatment of depression as well as neuropathic pain. By contrast, fluoxetine, paroxetine, mianserine, and zimelidine had IC(50)s for Na(V)1.7 outside their therapeutic concentration ranges and generally were not efficacious against post-herpetic neuralgia or diabetic neuropathy. These results suggest that block of peripheral nerve sodium channels may contribute to the antihyperalgesic efficacy of certain antidepressants. PERSPECTIVE: Tricyclic antidepressants are often considered first-line treatment for neuropathic pain. Some tricyclic antidepressants block sodium channels, which may contribute to their antihyperalgesic efficacy. In the current study, we compared the potency of peripheral sodium channel blockade for several tricyclic antidepressants and selective serotonin reuptake inhibitors with their therapeutic efficacy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17175203     DOI: 10.1016/j.jpain.2006.10.001

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  44 in total

1.  Amitriptyline does not block the action of ATP at human P2X4 receptor.

Authors:  J A Sim; R A North
Journal:  Br J Pharmacol       Date:  2010-03-19       Impact factor: 8.739

2.  Block of persistent late Na+ currents by antidepressant sertraline and paroxetine.

Authors:  Ging Kuo Wang; Jane Mitchell; Sho-Ya Wang
Journal:  J Membr Biol       Date:  2008-04-17       Impact factor: 1.843

Review 3.  Sodium channel blockers for the treatment of neuropathic pain.

Authors:  Anindya Bhattacharya; Alan D Wickenden; Sandra R Chaplan
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

Review 4.  Subtype-selective targeting of voltage-gated sodium channels.

Authors:  Steve England; Marcel J de Groot
Journal:  Br J Pharmacol       Date:  2009-10-20       Impact factor: 8.739

Review 5.  Nortriptyline for neuropathic pain in adults.

Authors:  Sheena Derry; Philip J Wiffen; Dominic Aldington; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2015-01-08

6.  Voltage-gated Na+ currents in human dorsal root ganglion neurons.

Authors:  Xiulin Zhang; Birgit T Priest; Inna Belfer; Michael S Gold
Journal:  Elife       Date:  2017-05-16       Impact factor: 8.140

Review 7.  Clinical pharmacology of analgesics assessed with human experimental pain models: bridging basic and clinical research.

Authors:  Bruno Georg Oertel; Jörn Lötsch
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

8.  Efficacy and tolerability of nortriptyline in the management of neuropathic corneal pain.

Authors:  M Cuneyt Ozmen; Gabriela Dieckmann; Stephanie M Cox; Ramy Rashad; Rumzah Paracha; Nedda Sanayei; Melina I Morkin; Pedram Hamrah
Journal:  Ocul Surf       Date:  2020-08-27       Impact factor: 5.033

Review 9.  Cellular and molecular mechanisms of pain.

Authors:  Allan I Basbaum; Diana M Bautista; Grégory Scherrer; David Julius
Journal:  Cell       Date:  2009-10-16       Impact factor: 41.582

10.  Blockade of Nav1.8 currents in nociceptive trigeminal neurons contributes to anti-trigeminovascular nociceptive effect of amitriptyline.

Authors:  Jingyao Liang; Xiaoyan Liu; Meiyan Pan; Wei Dai; Zhao Dong; Xiaolin Wang; Ruozhuo Liu; Jianquan Zheng; Shengyuan Yu
Journal:  Neuromolecular Med       Date:  2013-11-30       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.